Sponsor study identifier
interventional
58
1 country
1
Study Start
October 2, 2024
Actual (reported)Primary Completion
March 15, 2026
Actual (reported)Study Completion
June 2, 2026
Actual (reported)Participants are being asked to be a part of this study because they have been scheduled to receive a gum surgery to treat periodontal (gum) disease. After agreeing to participate a pain and medication log will be provided to participants and a 5 minute survey given. Standard of care gum surgery will be done using local anesthesia with or without intravenous sedation according to the participant's preference. If the participant is sedated, they will be asked to have an escort to take them home after the surgery as is the standard of care. At this visit, after the surgery is complete, the doctor will inject the area next to the area that surgery was done surgery with 4 ml (about a teaspoon) of one of two solutions decided by a random 1:1 draw. The participant will receive either liposomal bupivacaine (Exparel) which is a long-acting local anesthetic or 0.5% Bupivacaine HCl with a small amount of epinephrine, a medium-acting dental anesthetic. After surgery, as standard of care, participants will be given instructions on taking over-the-counter medications as needed for pain. Participants will be asked to fill out the pain survey and tablet log at specific times after leaving the clinic. A standard of care follow-up visit with the doctor will be scheduled about 2 weeks after the surgery.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2, 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2, 2024
Actual (reported)March 15, 2026
Actual (reported)June 2, 2026
Actual (reported)July 21, 2026
Actual (reported)July 24, 2026
Actual (reported)Post-operative pain measured with Numeric Rating Scale NRS-21 pain scale
Pain perceived at regular time intervals using a Visual Analogue Scale (NRS-21) rating their pain at specific time points on a scale from 0 to 10 with 0.5 points in between. A higher score indicates more pain.
3 to 168 hours
Time for numbness to wear off
3 to 168 hours
Number of of anti-inflammatory tablets taken
Baseline to 7 days
Number of analgesic tablets taken
Baseline to 7 days
The experimental group will receive a longer lasting formulation of bupivacaine (liposomal bupivacaine) as an adjunctive local infiltration
The control group will receive a commonly used in dentistry local anesthetic (0.5% bupivacaine HCL) as an adjunctive analgesic after the end of the procedure.
4 ml of bupivacaine 0.5% will be injected adjacent to the surgical site post-surgery
4 ml of Liposomal bupivacaine 13.3 mg/ml is injected adjacent to the surgical site post-surgery
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Angela Palaiologou-Gallis, DDS, MS
The University of Texas Health Science Center at San Antonio
58 participants (actual enrollment reported by the registry).
First Submitted
July 21, 2026
Local Anesthetic as Single Shot Versus Catheter in Patients Undergoing Video Assisted Thoracoscopic Surgery
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
First Posted
July 24, 2026
Study Start
October 2, 2024
Actual (reported)Primary Completion
March 15, 2026
Actual (reported)Study Completion
June 2, 2026
Actual (reported)Last Updated
July 27, 2026
Record last verified: 2026-07
The PI will ensure all mechanisms used to share data will include proper plans and safeguards for the protection of privacy, confidentiality, and security for data dissemination and reuse (e.g., all data will be thoroughly de-identified and will not be traceable to a specific study participant). Plans for archiving and long-term preservation of the data will be implemented, as appropriate.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: